NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2012 | $689,000 | Replaced |
| 2nd Quarter - Report (this page) | Oct 22, 2012 | $900,742 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicaid payment models - implementation of payment reforms included in HR 3590, including medical homes, pediatric accountable care, and Medicaid payment standards for primary care.
| Lobbyist | Covered position, as disclosed |
|---|---|
| M. JAMES KAUFMAN | — |
| JOHN KNAPP | — |
| JENNIFER LYNN RUDISILL | — |
Defense DEF
Lobbying on TRICARE coverage impacting children's health care benefits, specifically provisions regarding payment for speech and related therapies, and backing HR 4341, TRICARE for Kids legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| M. JAMES KAUFMAN | — |
| JOHN KNAPP | — |
| JENNIFER LYNN RUDISILL | — |
Health Issues HCR
HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| M. JAMES KAUFMAN | — |
| JOHN KNAPP | — |
| JENNIFER LYNN RUDISILL | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.